Pain-blocking gene mutation may hold clues for drug developers

Pharmaceutical researchers are studying a mutation in the SCN9A gene that makes patients immune to pain. While medications can mute pain, new experimental formulations that try to mimic the gene mutation aim to stop nerve cells from sending pain signals to the brain.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ